**Current Market Price of Hexaware Technologies Unlisted Shares: An Overview** Hexaware Technologies, a prominent IT and business process outsourcing (BPO)...

**Pristyn Care Seeks USD 100 Million Investment to Drive Expansion and Growth** Pristyn Care, a leading healthcare startup in India,...

# Indo Farm IPO Analysis: 10 Essential Insights for Investors The Indian stock market has been buzzing with activity, and...

**ISS Announces 2025 Benchmark Voting Policy Updates and Executive Compensation Guidelines FAQ** Institutional Shareholder Services (ISS), a leading provider of...

**Final Day Insights: Key Highlights on Subscriptions and GMPs for 3 IPOs Closing Today** The Indian stock market has been...

# Hero FinCorp IPO: 10 Essential Insights for Investors Hero FinCorp, a leading non-banking financial company (NBFC) in India, has...

**Oyo Expands North American Footprint with $525 Million Acquisition of G6 Hospitality** In a bold move to solidify its presence...

**Oyo Expands North American Operations with $525 Million Acquisition of G6 Hospitality** In a bold move to solidify its presence...

# Comprehensive Guide to Citichem India IPO: GMP, Review, Price, and Allotment Details The Indian stock market has been buzzing...

**Latest Update on NACDAC Infrastructure IPO: Grey Market Premium (GMP) Details Today** The Initial Public Offering (IPO) market in India...

**Q4 2024 Life Sciences Financing Trends: Quarterly Report and Insights** The life sciences sector, encompassing biotechnology, pharmaceuticals, medical devices, and...

**Q4 2024 Life Sciences Financing Trends: Quarterly Report and SPAC Insights** The life sciences sector has long been a cornerstone...

**Andhra Cement Receives SEBI Approval for INR 180 Crore Rights Issue** In a significant development for the Indian cement industry,...

**Celebrating 100 Episodes of “Don’t Take No for an Answer”: Thank You for Your Support!** In the ever-evolving world of...

**Celebrating 100 Episodes of ‘Don’t Take No for an Answer’: Thank You for Tuning In | SPAC Feed** In the...

**NACDAC Infrastructure IPO Subscription Status: Now Open for Bidding** The much-anticipated Initial Public Offering (IPO) of NACDAC Infrastructure has officially...

**NACDAC Infrastructure IPO Subscription Status Update – Now Open for Bidding** The much-anticipated Initial Public Offering (IPO) of NACDAC Infrastructure...

**Manoj Kohli, Ex-SoftBank India Head, Joins Zypp Electric as Senior Advisor** In a significant development for the burgeoning electric mobility...

**International Gemological IPO Now Open for Subscription – Latest Status Update** The global financial markets are abuzz with the latest...

**International Gemological IPO Now Open for Subscription: Current Status and Details** The global financial markets are abuzz with the latest...

**International Gemological IPO Now Open for Subscription – Check Status** The global financial markets are abuzz with the latest development...

**International Gemological IPO Now Open for Subscription: Current Status Update** The global financial markets are abuzz with the latest development...

# Comprehensive Guide to Ventive Hospitality IPO: Date, Review, Pricing, and Allotment Information The Initial Public Offering (IPO) market has...

**Ventive Hospitality IPO: Date, Review, Price, and Allotment Details** The hospitality industry has been buzzing with excitement as Ventive Hospitality,...

**Ventive Hospitality IPO: Key Details on Date, Review, Price, and Allotment Information** The hospitality industry has been buzzing with excitement...

**Ventive Hospitality IPO Details: GMP, Issue Price, Key Dates, and Allotment Information** The hospitality industry has been buzzing with excitement...

“Senores Pharmaceuticals IPO Achieves 14.65x Subscription on Day Two – IPO Watch”

**Senores Pharmaceuticals IPO Achieves 14.65x Subscription on Day Two – IPO Watch**

The Indian pharmaceutical industry has been buzzing with excitement as Senores Pharmaceuticals, a fast-growing player in the specialty pharmaceutical segment, launched its much-anticipated Initial Public Offering (IPO). On the second day of the subscription period, the IPO achieved a remarkable 14.65x subscription, signaling strong investor confidence in the company’s growth potential and market positioning.

### **Overview of the Senores Pharmaceuticals IPO**

Senores Pharmaceuticals, known for its focus on niche therapeutic areas and export-driven business model, opened its IPO for subscription on [insert date]. The offering comprises a mix of fresh equity shares and an offer for sale (OFS) by existing shareholders, with the total issue size pegged at ₹[insert amount] crore. The price band for the IPO was set at ₹[insert price range] per share, with a minimum lot size of [insert lot size] shares.

The funds raised through the IPO are expected to be utilized for capacity expansion, research and development (R&D) initiatives, repayment of debt, and general corporate purposes. The company’s robust financial performance, coupled with its strategic focus on high-margin products, has made the IPO a hot topic among retail and institutional investors alike.

### **Subscription Details**

By the end of the second day, the IPO had garnered an overwhelming response across all investor categories. According to data from the stock exchanges, the issue was subscribed 14.65 times overall, with the following breakdown:

– **Qualified Institutional Buyers (QIBs):** The QIB portion was subscribed [insert number] times, reflecting strong interest from domestic and foreign institutional investors. This is a clear indication of the company’s solid fundamentals and growth prospects.

– **Non-Institutional Investors (NIIs):** The NII category saw a subscription of [insert number] times, driven by high-net-worth individuals (HNIs) and corporate investors looking to capitalize on the company’s promising future.

– **Retail Individual Investors (RIIs):** The retail portion was subscribed [insert number] times, showcasing robust participation from small investors. The affordable price band and the company’s reputation in the pharmaceutical sector likely contributed to this enthusiastic response.

– **Employee Category (if applicable):** The reserved portion for employees was also fully subscribed, reflecting confidence among the company’s workforce.

### **What’s Driving the High Demand?**

Several factors have contributed to the overwhelming response to the Senores Pharmaceuticals IPO:

1. **Strong Industry Tailwinds:** The pharmaceutical sector in India has been witnessing significant growth, driven by increasing healthcare awareness, rising demand for generic drugs, and a focus on exports. Senores Pharmaceuticals, with its established presence in international markets, is well-positioned to benefit from these trends.

2. **Niche Product Portfolio:** The company specializes in complex generics and specialty pharmaceuticals, which are high-margin segments with limited competition. This strategic focus has enabled Sen